F. Cambazard

190 papers receiving 5.6k citations

F. Cambazard's Hit Papers

A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma 2015 · 586 citations
5860+3+7Years since publication100200300400500

Peers

F. Cambazard
Comparison fields: 5 of 117
  • Dermatology 2.2k
  • Immunology 786
  • Oncology 842
  • Cell Biology 284
  • Epidemiology 431
Replace Selim Aractingi with:
Selim Aractingi France
Antonio Torrelo Spain
Ramon Maria Pujol Spain
Robert George Phelps United States
Günther F.L. Hofbauer Switzerland
Emmanuella Guenova Switzerland
Hidemi Nakagawa Japan
Franco Rongioletti Italy
Antonio Cozzio Switzerland
J.‐P. Lacour France
F. Cambazard relative to Selim Aractingi France Selim Aractingi's profile →
Citations per field
00.5×1.5×2.0×
Selim Aractingi · 1×
Citations per year

Countries citing papers authored by F. Cambazard

Since Specialization
Citations

This map shows the geographic impact of F. Cambazard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Cambazard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Cambazard more than expected).

Fields of papers citing papers by F. Cambazard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Cambazard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Cambazard. The network helps show where F. Cambazard may publish in the future.

Co-authors

The 25 scholars most cited alongside F. Cambazard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F. Cambazard Line = papers co-authored together F. Cambazard links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
Hit paper breakdown →
2015586
2 2011429
3 2008301
4 2011207
5 2002199
6 2007199
7 2002189
8 2006184
9 2011145
10 2002140
11
Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa.
1991139
12 2002135
13 2005116
14 2004107
15 2016103
16 200984
17 201779
18 200177
19 200870
20 201867

About F. Cambazard

F. Cambazard is a scholar working on Dermatology, Oncology, Epidemiology, Immunology and Infectious Diseases, having authored 198 papers that have together received 5.9k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (35 papers), Cutaneous Melanoma Detection and Management (31 papers), Psoriasis: Treatment and Pathogenesis (15 papers), Nonmelanoma Skin Cancer Studies (15 papers), Dermatological diseases and infestations (12 papers), Genetic and rare skin diseases. (11 papers), Nail Diseases and Treatments (10 papers) and Histiocytic Disorders and Treatments (8 papers). The work is most often cited by research in Dermatology (2.2k citations), Immunology (786 citations), Oncology (842 citations), Cell Biology (284 citations) and Epidemiology (431 citations). F. Cambazard has collaborated with scholars based in France, Italy and Germany. Frequent co-authors include Jean Perrot, Bruno Labeille, Élisa Cinotti, Valerie Mengeaud, Thomas Ruzicka, John Berth‐Jones, Ramón Grimalt, Thomas Ludwig Diepgen, Sakari Reitamo and Catherine Douchet. Their work appears in journals such as British Journal of Dermatology, Journal of the European Academy of Dermatology and Venereology, Journal of the American Academy of Dermatology, Skin Research and Technology and Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact